SCF PATHOGENESIS REPORT
Hepatic Encephalopathy (HE) Ammonia Fault Architecture
PROJECT AMMONEX-HE
Document Code: SCF-HE-FA-0001
Objective:
Reverse-engineer the ammonia-driven pathophysiology of hepatic encephalopathy to identify actionable therapeutic intervention nodes for SCF-driven API discovery and preclinical development.
Framework aligned with the SCF Pathophysiology Protocol, multi-omics fault architecture mapping, and FDA translational research requirements.
I. ETIOPATHOGENIC CORE
Primary Disease Driver
Hepatic encephalopathy results from failure of the liver–gut detoxification axis leading to accumulation of ammonia and other neuroactive toxins that disrupt cerebral homeostasis.
Core Sequence
Gut Nitrogen Load
↓
Microbial Ammonia Production
↓
Impaired Hepatic Clearance
↓
Hyperammonemia
↓
Astrocyte Glutamine Overload
↓
Neuroinflammation
↓
Neural Network Dysfunction
↓
Cognitive & Motor Impairment
II. SCF FAULT ARCHITECTURE
TIER 1 — ORIGIN FAULTS
FAULT NODE A
Excess Gut Ammonia Generation
Primary Sources:
- Urease-producing bacteria
- Protein fermentation
- Gastrointestinal bleeding
- Dysbiosis
Key Molecular Targets:
- Urease
- TLR4
- NF-κB
- Endotoxin signaling
SCF Classification:
Primary Target Modulator Node
FAULT NODE B
Hepatic Detoxification Failure
Primary Systems:
- Urea cycle
- Periportal hepatocytes
- Glutamine synthetase system
Key Targets:
- CPS1
- OTC
- ASS1
- ASL
- ARG1
- GLUL
SCF Classification:
Metabolic Failure Node
TIER 2 — SYSTEMIC PROPAGATION
FAULT NODE C
Portal-Systemic Shunting
Consequences:
- Ammonia bypasses liver
- Reduced first-pass detoxification
- Increased systemic exposure
Clinical Significance:
Major determinant of overt HE severity.
SCF Classification:
Amplification Node
FAULT NODE D
Gut Barrier Failure
Mechanisms:
- Increased intestinal permeability
- Endotoxemia
- Microbial translocation
Molecular Markers:
- Zonulin
- Claudin-1
- Occludin
- LPS
SCF Classification:
Barrier Integrity Node
TIER 3 — BRAIN ENTRY
FAULT NODE E
Blood-Brain Interface Saturation
Mechanisms:
- Increased ammonia transport
- Neurotoxic metabolite exposure
- BBB dysfunction
Key Targets:
- Aquaporin-4
- GLUT1
- LAT1 transport systems
SCF Classification:
Neuro-Exposure Node
TIER 4 — ASTROCYTE FAILURE
FAULT NODE F
Glutamine Osmotic Overload
Central HE Event
Astrocytes convert:
Ammonia + Glutamate
↓
Glutamine
Excess glutamine causes:
- Cellular swelling
- Mitochondrial dysfunction
- Oxidative stress
SCF Classification:
Primary Neurotoxicity Node
FAULT NODE G
Mitochondrial Energy Collapse
Features:
- ATP depletion
- ROS accumulation
- Nitrosative stress
- Reduced neuronal support
SCF Classification:
Bioenergetic Collapse Node
This aligns with SCF bioenergetic fault architecture principles.
TIER 5 — NEUROIMMUNE CASCADE
FAULT NODE H
Microglial Activation
Drivers:
- Ammonia
- LPS
- Cytokines
Markers:
- TNF-α
- IL-1β
- IL-6
Consequences:
- Neuroinflammation
- Synaptic dysfunction
- Cognitive decline
SCF Classification:
Inflammatory Amplification Node
FAULT NODE I
Neurotransmitter Desynchronization
Affected Systems:
- GABAergic
- Glutamatergic
- Dopaminergic
- Serotonergic
Outcomes:
- Confusion
- Sleep disturbance
- Psychomotor slowing
SCF Classification:
Neural Desynchronization Node
III. MULTI-OMIC PATHOGENESIS MAP
Omics Layer | Principal Fault |
Genomics | Urea-cycle vulnerability genes |
Transcriptomics | Reduced ammonia detoxification expression |
Proteomics | Transporter and enzyme dysfunction |
Metabolomics | Hyperammonemia, glutamine accumulation |
Microbiomics | Urease-producing dysbiosis |
Interactomics | Cytokine network amplification |
Connectomics | Cortico-thalamic signaling disruption |
Biomechanicalomics | Astrocyte swelling and cerebral edema |
SCF multi-omic mapping methodology derived from the SCF Pathophysiology Protocol.
IV. SCF THERAPEUTIC INTERVENTION NODES
Node 1 — Ammonia Production
Goal:
Reduce gut ammonia generation.
Targets:
- Urease
- Protein fermentation pathways
- Dysbiotic taxa
Priority:
Very High
Node 2 — Gut Barrier Restoration
Goal:
Reduce endotoxin-driven amplification.
Targets:
- Tight junction proteins
- Mucosal immune signaling
Priority:
High
Node 3 — Hepatic Nitrogen Metabolism
Goal:
Increase ammonia clearance capacity.
Targets:
- Urea cycle enzymes
- Glutamine synthetase pathways
- Mitochondrial energetics
Priority:
Very High
Node 4 — Astrocyte Protection
Goal:
Prevent glutamine-mediated swelling.
Targets:
- Aquaporin-4
- Mitochondrial stress pathways
- ROS generation
Priority:
Very High
Node 5 — Neuroimmune Modulation
Goal:
Suppress inflammatory amplification.
Targets:
- NF-κB
- TNF-α
- IL-6
- NLRP3
Priority:
High
V. SCF PCR THERAPEUTIC ARCHITECTURE
Preventative
Prevent ammonia accumulation.
Targets:
- Gut microbiome
- Barrier function
- Nitrogen load
Curative
Reduce circulating ammonia and restore hepatic clearance.
Targets:
- Urea cycle
- Hepatic metabolism
- Microbial ammonia production
Restorative
Reverse neuroinflammation and neuronal dysfunction.
Targets:
- Astrocytes
- Microglia
- Mitochondrial function
VI. PROJECT AMMONEX-HE DISCOVERY TARGET HIERARCHY
Primary Targets
- Urease
- CPS1
- OTC
- GLUL
- Aquaporin-4
Secondary Targets
- TLR4
- NF-κB
- IL-6
- TNF-α
- NLRP3
Tertiary Targets
- SIRT1
- AMPK
- PPARα
- Tight-junction proteins
- Mitochondrial redox systems
RECOMMENDED NEXT COMMAND
API DISCOVERY
This will initiate:
- SCF Phase 1 Ethnobioprospecting
- Candidate source selection
- MoA/MeA extraction
- Target-to-compound mapping
- Novel ammonia-modulator API scaffold design
- SCF synergy scoring
- Preclinical development blueprint
MASTER REGISTRY INDEX
SCF-HE-FA-0001 — Hepatic Encephalopathy Fault Architecture
SCF-HE-PATH-0002 — Multi-Omic Pathogenesis Map
SCF-AMMONEX-HE-0003 — Ammonia Modulator Discovery Program
SCF-AMMONEX-HE-TGT-0004 — Therapeutic Target Hierarchy
SCF-AMMONEX-HE-PCR-0005 — Preventative–Curative–Restorative Architecture